Calpain‐mediated cleavage of p53 in human cytomegalovirus‐infected lung fibroblasts.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 3, p. 151, doi. 10.1096/fba.1028
- By:
- Publication type:
- Article
Works matching IS 25739832 AND DT 2019 AND VI 1 AND IP 3
Results: 6
1
2
Structural determinants and genetic modifications enhance BMP2 stability and extracellular secretion.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 3, p. 180, doi. 10.1096/fba.2018-00023
- By:
- Publication type:
- Article
3
Issue Information.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 3, p. 133, doi. 10.1096/fba.1045
- Publication type:
- Article
4
In search of the altering salivary proteome in metastatic breast and ovarian cancers.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 3, p. 191, doi. 10.1096/fba.2018-00029
- By:
- Publication type:
- Article
5
Insulin‐like growth factor binding protein‐4 exerts antifibrotic activity by reducing levels of connective tissue growth factor and the C‐X‐C chemokine receptor 4.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 3, p. 167, doi. 10.1096/fba.2018-00015
- By:
- Publication type:
- Article
6
S‐Nitrosated alpha‐1‐acid glycoprotein exhibits antibacterial activity against multidrug‐resistant bacteria strains and synergistically enhances the effect of antibiotics.
- Published in:
- FASEB Bioadvances, 2019, v. 1, n. 3, p. 137, doi. 10.1096/fba.1018
- By:
- Publication type:
- Article